From October 1, 2023 to October 25, 2023, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 11,614,548 shares, representing 1.25% for CNY 402.02 million under the buyback announced on December 6, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
38.98 CNY | -1.32% | +2.99% | +11.34% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.34% | 4.34B | |
+26.82% | 661B | |
+27.40% | 566B | |
-6.37% | 352B | |
+20.39% | 332B | |
+2.92% | 283B | |
+13.96% | 231B | |
+5.17% | 200B | |
-9.08% | 195B | |
-5.00% | 145B |
- Stock Market
- Equities
- 000513 Stock
- News Livzon Pharmaceutical Group Inc.
- Tranche Update on Livzon Pharmaceutical Group Inc.'s Equity Buyback Plan announced on December 6, 2022.